Signozid M 40mg/500mg Tablet

Introduction

Signozid M is a prescription medication that combines two active ingredients: Gliclazide and Metformin. It is used to help manage blood sugar levels in patients with type 2 diabetes.

Uses

Signozid M is prescribed to individuals with type 2 diabetes to help control their blood sugar levels. It is typically recommended as an adjunct to diet and exercise when these measures alone are not sufficient to manage blood glucose levels.

Dosage and Administration

The dosage of Signozid M will vary depending on individual patient factors, such as their current blood sugar levels and response to treatment. Follow the specific instructions provided by your healthcare professional.

Generally, Signozid M is taken orally with a meal. Your doctor will determine the appropriate dose and frequency of administration to best suit your needs. Take the medication as prescribed and not to exceed the recommended dose.

Mechanism of Action

Signozid M contains two active ingredients, Gliclazide and Metformin, which work together to help manage blood sugar levels.

Gliclazide belongs to a class of medications known as sulfonylureas. It stimulates the pancreas to produce more insulin, which helps lower blood sugar levels. By increasing insulin production, Gliclazide helps the body utilize glucose more effectively.

Metformin is a medication classified as a biguanide. It works by reducing glucose production in the liver and improving the body’s sensitivity to insulin. This helps lower blood sugar levels and improves the overall management of diabetes.

Side Effects

Common side effects that may occur include:

• Nausea
• Vomiting
• Diarrhea
• Stomach upset
• Headache

These side effects are usually mild and temporary. However, if they persist or become bothersome, consult your healthcare professional.

In rare cases, Signozid M may cause more serious side effects, such as:

• Low blood sugar (hypoglycemia): This can cause symptoms such as sweating, shaking, dizziness, and confusion. Be aware of the signs of low blood sugar and to take appropriate action, such as consuming glucose tablets or a sugary drink, if needed.
• Lactic acidosis: This is a rare but serious condition that can occur with the use of Metformin. Symptoms may include muscle pain, difficulty breathing, stomach discomfort, and unusual tiredness. If you experience any of these symptoms, seek immediate medical attention.

If you experience any unexpected or severe side effects while taking Signozid M, contact your healthcare professional right away.

Drug Interactions

Signozid M may interact with other medications, including over-the-counter drugs and herbal supplements. Some common drug interactions to be aware of include:

• Certain antibiotics: Some antibiotics may interact with Signozid M and affect its effectiveness. Inform your healthcare professional about all medications you are taking.
• Certain heart medications: Some heart medications may interact with Signozid M, potentially causing changes in blood sugar levels. Discuss all your medications with your healthcare professional.

Inform your healthcare professional about all medications you are taking to avoid potential interactions. They can provide guidance on any necessary adjustments to your treatment plan.

Precautions

Before starting Signozid M, inform your healthcare professional about any existing medical conditions or allergies you may have. Additionally, discuss all medications you are currently taking, including over-the-counter drugs and herbal supplements.

Certain precautions and contraindications to be aware of include:

• Hypersensitivity to Gliclazide, Metformin, or any other ingredients in the medication
• Severe kidney or liver disease
• Conditions that may lead to dehydration, such as severe infections or surgery
• Alcohol use
• Pregnancy or breastfeeding

follow your healthcare professional’s guidance and recommendations regarding the use of Signozid M.

Storage

Signozid M should be stored at room temperature, away from excessive heat, moisture, and light. Keep the medication out of reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

Here are some additional tips for patients using Signozid M:

• Take the medication as prescribed: follow your healthcare professional’s instructions and take the medication as prescribed. Do not skip doses or exceed the recommended dosage.
• Monitor your blood sugar levels: Regularly monitor your blood sugar levels as directed by your healthcare professional. This will help you and your doctor determine the effectiveness of the medication and make any necessary adjustments to your treatment plan.
• Maintain a healthy lifestyle: Signozid M is most effective when combined with a healthy diet and regular exercise. Follow a well-balanced meal plan and engage in regular physical activity to help manage your diabetes.
• Be aware of signs of low blood sugar: Learn the signs and symptoms of low blood sugar and have a plan in place to address it if it occurs. Carry a source of fast-acting glucose, such as glucose tablets or a sugary drink, with you at all times.
• Attend regular check-ups: Regularly visit your healthcare professional for check-ups and to monitor your diabetes management. They can assess your progress, make any necessary adjustments to your treatment plan, and address any concerns or questions you may have.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Gliclazide: a medicine to treat type 2 diabetes (NHS UK) [Accessed 10 Jun. 2024] (online) Available at:
• Dacadis MR 30mg Modified Release Tablets (Health Professionals SmPC) Available at:
• Gliclazide (International database) (Drugs.com) [Accessed 30 Jun. 2024] (online) Available at:
• metformin (RX) [Accessed 21 Jun. 2024] (online) Available at:
• Oral hypoglycemics overdose (MedlinePlus) [Accessed 9 Jun. 2024] (online) Available at:
• Tomlinson B, Li YH, Chan P. Evaluating gliclazide for the treatment of type 2 diabetes mellitus. Expert Opin Pharmacother. 2022 Dec;23(17):1869-1877. doi: 10.1080/14656566.2022.2141108. Epub 2022 Nov 10. [Accessed 21 Jun. 2024] Available at: